HFA Premium Access

Ivabradine treatment for chronic heart failure in clinical practice is associated with reductions in symptoms and hospitalizations with improved quality of life, independent of beta blocker dose

Congress Presentation

About the speaker

Professor Christian Zugck

Kardiologische Praxis im Steiner Thor, Straubing (Germany)
0 follower

9 more presentations in this session

Assessment of the use of ESC heart failure guideline recommended therapy among patients followed at a heart failure outpatient clinic participating in the ESC Heart Failure long-term Registry

Speaker: Doctor B. Muk (Budapest, HU)


Long-term follow up of hospitalized patients with systolic heart failure undergoing early treatment with beta-blockers more ivabradine: a randomized study

Speaker: Doctor F. Hidalgo Lesmes (Cordoba, ES)


Comparison of perindopril-amlodipine and losartan-amlodipine combinations in the management of hypertension in patients with metabolic syndrome

Speaker: Doctor J. Uzokov (Tashkent, UZ)


How do we use anticoagulation therapy in the era of novel drugs - results of FIRST II registryy

Speaker: Doctor T. Novakova (Brno, CZ)


Cardioprotective effects of long-term high-dose therapy with atorvastatin in patients with STEMI in the prevention of chronic heart failure

Speaker: Professor V. Oleinikov (Penza, RU)


Access the full session

Poster Session 3 - Drug therapy, other

Speakers: Professor C. Zugck, Doctor B. Muk, Doctor F. Hidalgo Lesmes, Doctor J. Uzokov, Doctor T. Novakova...

About the event



21 May - 24 May 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb